Virpax Pharmaceuticals Set for Transformative Year with High Hopes for Non-Addictive Pain Management Solutions

23d ago, source: MyChesCo on MSN

BERWYN, PA — Recent developments have been flourishing for Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX). The ...

Virpax Pharmaceuticals Inc Ordinary Shares VRPX

8d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Virpax Pharmaceuticals Reports 2023 Year-End Results

1mon ago, source: Stockhouse

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain ...

Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference May 10-11, 2023

11mon ago, source: ADVFN

Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder ...

PCSA Processa Pharmaceuticals, Inc.

2mon ago, source: Seeking Alpha

Processa Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing the chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are ...

PTPI Petros Pharmaceuticals, Inc.

19d ago, source: Seeking Alpha

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men’s health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications ...

Virpax Pharmaceuticals Inc Ordinary Shares

14d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Virpax Pharmaceuticals Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Virpax Pharmaceuticals Reports 2023 Year-End Results

1mon ago, source: Finanznachrichten

BERWYN, Pa.--(BUSINESS WIRE)--Virpax ® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ: VRPX), a company specializing in developing non-addictive products ...

Virpax Pharmaceuticals Reports 2023 Year-End Results

1mon ago, source: Yahoo Finance

BERWYN, Pa., March 26, 2024--(BUSINESS WIRE)--Virpax ® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management ...